Filing Details

Accession Number:
0001179110-14-015608
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-20 18:16:49
Reporting Period:
2014-10-17
Filing Date:
2014-10-20
Accepted Time:
2014-10-20 18:16:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1274057 Hospira Inc HSP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1372882 E Thomas Werner C/O Hospira, Inc.
275 North Field Drive
Lake Forest IL 60045
Svp, Finance & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-17 10,000 $43.18 64,614 No 4 M Direct
Common Stock Disposition 2014-10-17 10,000 $50.04 54,614 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2014-10-17 10,000 $0.00 10,000 $43.18
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
31,566 2015-03-05 No 4 M Direct
Footnotes
  1. Exercise of derivative security exempted pursuant to Rule 16b-3.
  2. The stock options vest in three equal annual installments on March 6, 2009, 2010, and 2011. The exercise price of $43.18 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, which expire on March 5, 2015.